Aarti Pharmalabs
Aarti Pharmalabs Performance
Day Range
- Low 454.55
- High 466.2
52 Week Range
- Low 234.8
- High 476.05
- Open Price454.6
- Previous Close450.3
- Volume129514
Start SIP in Aarti Pharmalabs
Start SIPAarti Pharmalabs Investment Rating
-
Master Rating:
-
Aarti Pharmalabs has an operating revenue of Rs. 2,863.89 Cr. on a trailing 12-month basis. An annual revenue growth of 62% is outstanding, Pre-tax margin of 13% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 18% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 11% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Mar 2022 |
---|---|---|---|---|
Oper Rev Qtr Cr | 358 | 374 | 1,137 | 365 |
Operating Expenses Qtr Cr | 281 | 297 | 905 | 296 |
Operating Profit Qtr Cr | 77 | 77 | 232 | 68 |
Depreciation Qtr Cr | 15 | 14 | 42 | 12 |
Interest Qtr Cr | 4 | 6 | 15 | 4 |
Tax Qtr Cr | 15 | 17 | 45 | 9 |
Net Profit Qtr Cr | 48 | 40 | 132 | 45 |
Aarti Pharmalabs Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹435.17
- 50 Day
- ₹407.02
- 100 Day
- ₹380.01
- 200 Day
- ₹
- 20 Day
- ₹439.74
- 50 Day
- ₹391.13
- 100 Day
- ₹380.22
- 200 Day
- ₹
Aarti Pharmalabs Resistance and Support
Resistance | |
---|---|
First Resistance | ₹467.25 |
Second Resistance | ₹472.55 |
Third Resistance | ₹478.9 |
RSI | 65.8 |
MFI | 49.55 |
MACD Single Line | 17.86 |
MACD | 16.34 |
Support | |
---|---|
First Resistance | ₹455.6 |
Second Resistance | ₹449.25 |
Third Resistance | ₹443.95 |
Aarti Pharmalabs Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 139,538 | 8,405,769 | 60.24 |
Week | 124,585 | 6,788,615 | 54.49 |
1 Month | 341,180 | 18,297,468 | 53.63 |
6 Month | 305,205 | 17,155,579 | 56.21 |
Aarti Pharmalabs Result Highlights
Aarti Pharmalabs Synopsis
NSE-Medical-Ethical Drugs
Aarti Pharmalabs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1511.25 Cr. and Equity Capital is Rs. 45.31 Cr. for the Year ended 31/03/2023. Aarti Pharmalabs Ltd. is a Public Limited Listed company incorporated on 22/11/2019 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2019PLC110964 and registration number is 110964.Market Cap | 4,186 |
Sales | 1,869 |
Shares in Float | 4.89 |
No of funds | 136 |
Yield |
Book Value | 2.91 |
U/D Vol ratio | 2.3 |
LTDebt / Equity | |
Alpha | 0.18 |
Beta | 0.4 |
Aarti Pharmalabs
Owner Name | Jun-23 | Mar-23 | Jan-23 |
---|---|---|---|
Promoters | 45.98% | 45.98% | 44.16% |
Mutual Funds | 2.72% | 5.11% | 6.7% |
Insurance Companies | 7.06% | 7.73% | 8.01% |
Foreign Portfolio Investors | 7.43% | 7.69% | 11.89% |
Financial Institutions/ Banks | 0.02% | 0.02% | 0.02% |
Individual Investors | 30.23% | 28.35% | 24.66% |
Others | 6.56% | 5.12% | 4.56% |
Aarti Pharmalabs Management
Name | Designation |
---|---|
Mr. Chandrakant Vallabhaji Gogri | Chairman Emeritus |
Mr. Rashesh C Gogri | Chairman & Non-Exe.Director |
Mrs. Hetal Gogri Gala | Vice Chairperson & M.D |
Mr. Narendra J Salvi | Managing Director |
Mr. Rajendra V Gogri | Non Executive Director |
Mr. Parimal H Desai | Non Executive Director |
Mr. Bhavesh R Vora | Independent Director |
Mrs. Jeenal K Savla | Independent Director |
Mrs. Rupal A Vora | Independent Director |
Mr. Vilas Gajanan Gaikar | Independent Director |
Mr. Vinay G Nayak | Independent Director |
Aarti Pharmalabs Forecast
Price Estimates
Aarti Pharmalabs Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-05 | Quarterly Results | |
2023-05-12 | Audited Results |
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Aarti Pharmalabs FAQs
What is Share Price of Aarti Pharmalabs ?
Aarti Pharmalabs share price is ₹461 As on 30 September, 2023 | 05:58
What is the Market Cap of Aarti Pharmalabs ?
The Market Cap of Aarti Pharmalabs is ₹4186.5 Cr As on 30 September, 2023 | 05:58
What is the P/E ratio of Aarti Pharmalabs ?
The P/E ratio of Aarti Pharmalabs is As on 30 September, 2023 | 05:58
What is the PB ratio of Aarti Pharmalabs ?
The PB ratio of Aarti Pharmalabs is 2.7 As on 30 September, 2023 | 05:58